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Abstract 
Background: To compare serum hepcidin levels of 
patients with hepatitis C induced diabetes mellitus 
with healthy controls 
Methods: Sixty individuals were included in the 
study. Thirty were diagnosed cases of chronic 
hepatitis C who developed diabetes mellitus  during 
the course of HCV infection. Thirty age and gender 
matched healthy controls were included. Individuals 
with acute hepatitis C, familial diabetes mellitus, 
iron deficiency anemia, recent history of blood 
transfusion, iron or erythropoietin supplementation 
and inflammatory diseases like rheumatoid arthritis, 
renal, cardiac, pulmonary diseases and on interferon 
therapy were excluded from the study. Blood 
samples were collected from all the individuals and 
serum hepcidin levels were measured by ELISA.  
Results: Significant decrease in serum hepcidin 
levels was found in patients with the chronic 
hepatitis C and diabetes mellitus having mean value 
of 2.7±1.03ng/ml as compared with controls having 
mean value of 28.5±5.3ng/ml. The difference among 
the two groups was significant at p-value of <0.001. 
Conclusion: Serum hepcidin levels in patients 
with chronic hepatitis C with diabetes mellitus are 
significantly less as compared to healthy controls. 
Key Words: Hepcidin, hepatitis C induced 
diabetes mellitus 
Introduction 
Hepatitis C virus (HCV) is notorious for causing acute 
and chronic liver disease worldwide.1  It is an RNA 
virus that belongs to family Flaviviradae. According to 
an estimate in 85% of the cases, acute HCV infection 
becomes chronic and 10% of the population in 
Pakistan is chronically infected with Hepatitis C virus.2 
 HCV infection becomes chronic when its RNA persists 
in blood for more than 6 months and is frequently 
associated with extra-hepatic manifestations such as 
diabetes, arthralgias and thyroiditis. About one third 
of the chronically infected population develops 
diabetes.3  The important feature of pathogenesis of 
HCV induced diabetes is the development of insulin 
resistance. 4  Numerous mechanisms have been 
proposed to explain this insulin resistance including 
upregulation of inflammatory cytokines, 
hypophosphorylation of insulin receptor substrate-1 
and 2, upregulation of gluconeogenic and lipogenic 
genes, accumulation of lipids and targeting lipid 
storage organelles. 2  The infection by hepatitis C virus 
is characterized by hepatocyte injury and iron 
overload has been identified as one of the factors 
behind it. 5   
Hepcidin, a biologically active hepatic peptide, is 
known as the major regulator of body iron 
metabolism.6  It is synthesized primarily by 
hepatocytes. However, kidney tissue, pancreatic beta 
cells, macrophages and adipocytes have also been 
reported as the other sites of hepcidin production.7  
Regulation of iron homeostasis is mainly carried out 
by binding iron efflux channels called ferroportin [8] 
which are responsible for iron export from enterocytes 
and macrophages.7  Hepcidin binds these iron 
exporting channels and cause their internalization and 
degradation thus decreasing iron export into blood.8  
The expression of hepcidin is regulated at 
transcription level by bone morphogenetic protein 
(BMP). Other cofactors involved in iron dependent 
regulation of hepcidin expression are 
haemochromatosis protein HFE, TfR2 (Tf receptor2), 
HJV (haemojuvelin), TMPRSS6.8  Its transport in blood 
is in free form as well as bound to α-macroglobulin 
and the excretion is by kidney. 9  Conditions involving 
oxidative stress, hypoxia, erythropoietin  or vitamin D 
therapy  have been reported to decrease serum 
hepcidin levels whereas conditions involving 
inflammation, infection or iron supplementation 
increase serum hepcidin levels.5, 9-12  Excess iron 
resulting from altered levels of hepcidin activates 
inflammatory cells and hepatic stellate cells and 
catalyzes the production of reactive oxygen species 
(ROS) and inflammatory cytokines which then evoke 
fibrosis. 8,13 Chronic HCV infection causes iron 
accumulation by hepcidin suppression which has been 
proposed as major mechanism responsible for causing 
glucose intolerance by influencing insulin signaling. 14 
The accumulated iron causes increased glucose 
production by hepatocytes, increased fatty acid 
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oxidation and decreased glucose oxidation in skeletal 
muscles and adipocytes and altered levels of 
adipokines in adipocytes.15 Furthermore, it causes 
oxidative stress, a factor independently responsible for 
causing insulin resistance. The resultant 
hyperinsulinemia then causes rapid iron uptake by 
liver since insulin redistributes transferrin receptors 
from an intracellular compartment to cell membrane 
and further exacerbates iron overload.16 
Patients and Methods 
In this descriptive study thirty adults of either gender 
with Blood Sugar Fasting (BSF) <110mg/dl (for group 
I), diagnosed patients with HCV infection for 
>6months and diabetes mellitus (for group II) were 
included via non-probability purposive sampling. 
After recording detailed history of every individual 
followed by general physical examination, individuals 
with acute Hepatitis C, familial diabetes, interferon 
therapy, iron deficiency anemia, recent history of 
blood transfusion, iron or erythropoietin 
supplementation and inflammatory diseases like 
rheumatoid arthritis, renal, cardiac, pulmonary and 
hepatic diseases (other than HCV infection) were 
dropped . Blood sampling was then done after a 12 
hour overnight fast for the measurement of serum 
glucose, serum insulin and serum hepcidin levels. 5ml 
of blood was collected by venipuncture under aseptic 
measures from each individual and was transferred to 
gel separator tubes. It was allowed to clot and the 
clotted sample was then centrifuged at 2000-3000rpm 
for 20 minutes. The separated serum was then 
pippetted out into the polypropylene tubes for storage 
at -20oC until analysis .Serum glucose levels were 
estimated at the  time of sampling while serum 
hepcidin levels were measured by enzyme linked 
immunosorbent assay   (Glory sciences, human 
hepcidin ELISA kit). . Means and standard deviations 
were calculated for quantitative variables like age, 
fasting blood sugar levels (BSF) and serum hepcidin 
levels whereas percentage and frequency were 
calculated for categorical variables. Serum hepcidin in 
the two groups were compared by independent t-test 
and correlation between the BSF and serum hepcidin 
levels was found by Pearson’s correlation and p-value 
of <0.05 was considered statistically significant. 
Results 
In present study, sixty individuals were included. 
Group 1 (n=30) involved healthy controls of mean age 
of 63.1± 12.3 years while the group 2 (n=30) included 
patients with hepatitis as well as diabetes mellitus, 
having mean age of 67.3±10.6 years. There was no 
significant difference between the ages of the two 
groups. In group 1, 21 were male while 9 were female. 
On the other hand group 2 included 22 male and 8 
female. There was no significant difference between 
the gender representations in the two groups (Table 
1).The mean values of BSF in mmol/L in the two 
groups were compared via independent samples t-test 
as well and were found to be significantly different in 
the two groups at p-value of <0.001. The BSF values 
were noted to be significantly higher in group 2 (12.1± 
3.1mmol/l) as compared to group 1 (5±1.3mmol/l) 
(Table 2). The significantly negative correlation of BSF 
with serum hepcidin revealed about 77% association 
between the two parameters and showed that glucose 
levels in blood are significantly increased with the 
decreasing hepcidin levels in patients with CHC 
induced diabetes.Mean values of serum hepcidin were 
found to be significantly different in the two groups at 
p-value of 0.000.  
Table 1: Comparison of ages and male to female 
of the healthy controls and cases 
Parameters Group 1 
(healthy controls) 
Group 2 
(Cases with 
HCV and DM) 
Age 63.1±12.3 years 67.3±10.6years 
N 30 30 
Male: female 21 : 9 22 : 8 
Table 2: Comparison of serum hepcidin levels and 
BSF (mmol/L) between the two groups 
Parameters Group 1 
(Healthy 
controls) 
Group 2 
(cases with 
HCV and 
DM) 
p-value 
Blood sugar 
fasting (mmol/L) 
5±1.3 12.1± 3.1 0.000* 
Serum hepcidin 
(ng/ml) 
28.5± 5.3 2.7± 1.03 0.000* 
*p-value is significant (<0.001) 
The mean values of group 2 (2.7±1.03ng/ml) were 
found to be significantly lower as compared to the 
values observed in group 1 (28.5± 5.3ng/ml) (Table 2). 
Levels of serum hepcidin showed significant negative 
correlation with BSF levels at r-value of -0.769 and p-
value of 0.000. The above mentioned observations not 
only confirm the suppressing action of CHC on serum 
hepcidin levels but also validate the negative 
association of hepcidin with rising BSF seen in HCV 
induced diabetes. 
Discussion 
In present  study decreased serum hepcidin levels 
were found in patients with hepatitis C induced 
diabetes mellitus as compared with the healthy 
controls. It shows that suppression of hepcidin is 
associated with the development of diabetes mellitus 
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in chronic hepatitis C. The probable mechanism 
behind the development of this extrahepatic 
manifestation is the role of hepcidin in the regulation 
of iron metabolism. Thus, suppression of hepcidin 
results in decreased internalization and degradation of 
iron transporting channels, ferroportin. The ensuing 
increased and uninhibited transport of iron then 
causes iron overload. This iron accrual causes 
decreased glucose oxidation and increased lipid 
breakdown in adipocytes, results in increased fatty 
acid oxidation and decreased glucose oxidation in 
muscles and in hepatocytes causing increased glucose 
production ,thus causing insulin resistance and 
hyperglycemia and forming a picture identical to 
diabetes mellitus.15 Accumulated iron stimulates 
inflammatory cells and hepatic stellate cells which 
then play role in mounting reactive oxygen species 
and progression of hepatic fibrosis, independently 
infamous as a risk factor for the development of 
insulin resistance.16 The results of our study are 
comparable to Girelli et al. who measured serum 
hepcidin in 81 untreated chronic hepatitis C patients 
and 57 healthy controls and found a significant 
decrease in CHC patients 33.7 versus 90.9 ng/ml 
respectively (p-value  <0.001).17 Similarly Tsochatzis et 
al. found a decrease in serum hepcidin levels in CHC 
patients as compared to healthy individuals. They 
included 96 chronic cases of hepatitis C and 30 
controls and found significantly decreased serum 
hepcidin levels by ELISA, 14.6±7.3 versus 34.3±17.3 
ng/ml at the p-value of <0.001. 18 The values in our 
study are although generally lower which could be 
due to difference in the kit used yet, the difference 
between the serum hepcidin levels of controls and 
cases is nearer to that reported by Tsochatzis et al. 
(20.3ng/ml) that is 25.1ng/ml. The difference reported 
by Girelli et al. is much larger which may be explained 
by the large difference between the ages of controls 
and cases (35 versus 42.2 years). The association of 
hepcidin with standard endocrine type 2 diabetes 
mellitus has been reported by Wang et al. in Sprague-
Dawley rats. He showed a 40% decrease in hepatic 
hepcidin expression in rats with streptozotocin 
induced type 2 diabetes mellitus. 19 Gan et al. reported 
lowering of risk of diabetes mellitus in individuals 
with hepcidin suppressing mutations of TMPRSS 6 
(transmembrane protease serine 6).20. 
Conclusion 
1.Aberrations in glucose metabolism have been 
frequently linked with altered body iron regulation 
and in present study similar association is found  
between hepatitis C induced diabetes mellitus and 
hepcidin, the major iron regulating hormone.  
2.Suppressed levels of hepcidin,in hepatitis C patients, 
explains the iron accrual and resulting alteration in 
glucose metabolism thus providing a substance that 
can help in assessment of disease progression and 
stratification for the risk of development of diabetes 
mellitus in patients with chronic hepatitis C.   
References 
1. Afdhal  NH. The natural history of hepatitis C. Semin Liver Dis, 
2004;24( 2): 3-8. 
2. Parvaiz F,  Manzoor S, Tariq H,   Javed F.Hepatitis C virus 
infection: molecular pathways to insulin resistance. Virol J, 
2011; 8:  474-77. 
3. Safi  SZ Shah S,Yan GO, Qvist R. Insulin resistance provides the 
connection between hepatitis C virus and diabetes. Hepat Mon, 
2015; 15(1):2394-97. 
4. Lecube, A. Hernández C, Genescà J. Proinflammatory cytokines, 
insulin resistance, and insulin secretion in chronic hepatitis C 
patients. Diabetes Care, 2006;29(5):1096-1101. 
5. Miura K, Taura K, Kodama Y,Schanabi Y. Hepatitis C virus-
induced oxidative stress suppresses hepcidin expression through 
increased histone deacetylase activity. Hepatology, 2008; 48(5): 
1420-29. 
6. Liu, H  Trinh TL, Dong H, Keith HR, Nelson D. Iron regulator 
hepcidin exhibits antiviral activity against hepatitis C virus. 
2012. PLoS One 
7. Aregbesola, A.,Voutelian S,Vitranan JK.Serum hepcidin 
concentrations and type 2 diabetes. World journal of diabetes, 
2015;6(7): 978-81. 
8. Wang J. and Pantopoulos K. Regulation of cellular iron 
metabolism. Biochem J, 2011; 434(3): 365-81. 
9. Huang ML, Austin CJ,Sari MA. Hepcidin reduces ferroportin-1 
expression and enhances its activity at reducing iron levels. J 
Biol Chem, 2013;288(35): 25450-65. 
10. Ganz T. Hepcidin and iron regulation, 10 years later. Blood, 
2011;117(17):4425-33. 
11. Bacchetta, J., Zaritsky JJ, Sea JL, Chun RF. Suppression of iron-
regulatory hepcidin by vitamin D. J Am Soc Nephrol, 2014; 
25(3):564-72. 
12. Sany D and  Elsawy AE, ElshahawyY.Hepcidin and regulation of 
iron homeostasis in maintenance hemodialysis patients. Saudi J 
Kidney Dis Transpl, 2014; 25(5): 967-73. 
13. Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli . 
Cytokines and HCV-related disorders. Clin Dev Immunol, 2012; 
2012; 468107-10. 
14. Corradini E. and Pietrangelo A. Iron and steatohepatitis. Journal 
of gastroenterology and hepatology, 2012;27(s2):42-46. 
15. Basuli, D.,  Stevens RG, Torti FM, Tort SV.. Epidemiological 
associations between iron and cardiovascular disease and 
diabetes. Front Pharmacol, 2014;5: 117-20. 
16. El-Zayadi AR and Anis M. Hepatitis C virus induced insulin 
resistance impairs response to anti viral therapy. World J 
Gastroenterol, 2012;18(3): 212-24. 
17. Girelli, D., et al., Reduced serum hepcidin levels in patients with 
chronic hepatitis C. J Hepatol, 2009. 51(5): p. 845-52. 
18. Tsochatzis, E.,  Papatheodoridis GV, Koliaraki V. Hepcidin levels 
are related to severity of liver histological lesions in chronic 
hepatitis C. J Viral Hepat, 2010;17(11): 800-06. 
19. Wang H,  Li H, Jiang X, Shi W, Shen Z. Hepcidin is directly 
regulated by insulin and plays an important role in iron overload 
. Diabetes, 2014;63(5): 1506-8. 
20. Gan, W., Guan Y, Wu Q, An P.Association of TMPRSS6 
polymorphisms with ferritin, hemoglobin, and type 2 diabetes 
risk in a Chinese Han population. The American journal of 
clinical nutrition, 2012;95(3): 626-32. 
 
 
